BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.
Bioxcel Therapeutics stock last closed at $1.71, down 1.72% from the previous day, and has decreased 96.25% in one year. It has underperformed other stocks in the Biotechnology industry by 0.19 percentage points. Bioxcel Therapeutics stock is currently +32.56% from its 52-week low of $1.29, and -96.49% from its 52-week high of $48.72.
As of Apr 21, 2025, there are 5.49M shares of BTAI outstanding. The market value of BTAI is $9.38M. In the last 24 hours, 59,228 BTAI shares were traded.
How to Buy Bioxcel Therapeutics Stock
Wondering how to invest in Bioxcel Therapeutics stock? Here's how.
Choose where to buy Bioxcel Therapeutics stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Bioxcel Therapeutics stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Put funds into your investment account: Select your payment method and add your details.
Evaluate Bioxcel Therapeutics stock: The Bioxcel Therapeutics ticker symbol is BTAI. Is Bioxcel Therapeutics stock a good investment? Should you buy shares of BTAI? How do BTAI's underlying business fundamentals look? Do top analysts think Bioxcel Therapeutics is a good buy? Why has BTAI's stock price moved recently? (Hint: Our stock market analysis website can help you understand if BTAI is a good stock to buy).
Execute your BTAI purchase: Decide if you will purchase BTAI shares at the current market price or use a limit order to purchase BTAI stock at a particular price.
Get the latest news on your investment in BTAI: Create a watchlist to get live updates on your investment in Bioxcel Therapeutics shares.
Step 1: Choose where to buy Bioxcel Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy BTAI shares.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal info so you can buy BTAI stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Bioxcel Therapeutics stock
After you have chosen the best place to buy Bioxcel Therapeutics stock, it's very important to evaluate their stock prior to buying, so you actually wrap your head around the risk and upside.
Bioxcel Therapeutics shares at a glance
BTAI Price
$1.71
1w %
-10.94%
1y %
-96.25%
5y %
-99.61%
P/E
-0.07x
P/B
-0.1x
P/S
1.91x
PEG
N/A
Revenue
$2.27M
Earnings
-$59.60M
Fore. Rev. Growth
281.77%
Fore. Earn. Growth
N/A
Market Cap
$9.38M
Next Earnings
May 7, 2025
Next Dividend
N/A
BTAI Overview
WallStreetZen was built to help average investors do more in-depth fundamental analysis in minutes instead of hours.
Last year, BTAI revenue was $2.27M. Over the last 2 year, BTAI's revenue has gone up by 145.82% per year. This was faster than the Biotechnology industry average of 44.31%.
No, Bioxcel Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about BTAI?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your BTAI purchase
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at an exact dollar amount limit, use a limit order.
Hit the Open button and your broker will place the order.
If you need additional help buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Bioxcel Therapeutics share?
As of Apr 21, 2025, it costs $1.71 to buy one share of Bioxcel Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.86, you can buy 0.5 shares of BTAI.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.